butabarbital decreases outcomes of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of CYP3A4 inducers may well decrease sufentanil stages and efficacy, maybe precipitating withdrawal syndrome in patients who've made Actual physical dependence to sufentanil. Discontinuat